This paper explores the relationship between open innovation (OI) and firm's network position on enhancing firm's innovation performance, such as new product development (NPD). We build a theoretical framework and test it on the biopharmaceutical context. Our result shows how firm's network position influences NPD performance obtained through OI practices.
Mazzola, E., Perrone, G. (2013). Does firm’s network position enhance open innovation performance? Evidences from the biopharmaceutical industry. In 24th Annual POM Conference. Denver, Colorado, USA, May 3 – 6, 2013 (pp.1-10).
Does firm’s network position enhance open innovation performance? Evidences from the biopharmaceutical industry
MAZZOLA, Erica;PERRONE, Giovanni
2013-01-01
Abstract
This paper explores the relationship between open innovation (OI) and firm's network position on enhancing firm's innovation performance, such as new product development (NPD). We build a theoretical framework and test it on the biopharmaceutical context. Our result shows how firm's network position influences NPD performance obtained through OI practices.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
POMS full paper_Mazzola and Perrone .pdf
Solo gestori archvio
Descrizione: Main Article
Dimensione
216.44 kB
Formato
Adobe PDF
|
216.44 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
